Abstract A25: Urokinase Plasminogen Activator Expression Is Regulated by P53 Harboring the Lung Cancer-Specific Mutation V157F

doi 10.1158/1557-3265.aacriaslc18-a25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research

Related search

Imaging Active Urokinase Plasminogen Activator in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2015English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Role of Urokinase Plasminogen Activator Receptor–Associated Protein in Mouse Lung

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2012English

Urokinase-Type Plasminogen Activator Expression Correlates With Tumor Angiogenesis and Poor Outcome in Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2003English

Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)

Science-Business eXchange
2013English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Urokinase Expression by Tumor Suppressor Protein P53

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2008English

Full-Length Soluble Urokinase Plasminogen Activator Receptor Down-Modulates Nephrin Expression in Podocytes

Scientific Reports
Multidisciplinary
2015English

Effect of Urokinase Antiserum on Plasminogen Activators: Demonstration of Immunologic Dissimilarity Between Plasma Plasminogen Activator and Urokinase

Journal of Clinical Investigation
Medicine
1968English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy